Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Pinaverium bromidePDL I DEC / 13
PinazepamTS I JUN / 02
Pindolol or its saltsPDL I DEC / 13
Pioglitazone or its saltsPDL I DEC / 13
Pipecuronium bromidePDL I DEC / 13
Piperacetazine or its saltsPDL I DEC / 13
Piperazine and its salts II SEP / 98
Piperilate or its saltsPDL I DEC / 13
PipobromanPDL I DEC / 13
Pipotiazine or its saltsPDL I DEC / 13
Pipradol and any salt thereofTS I SEP / 98
Pirbuterol or its saltsPDL I DEC / 13
Pirenzepine or its saltsPDL I DEC / 13
Pirfenidone or its derivativesPDL I DEC / 13
Pirlimycin or its saltsPDL I DEC / 13
Piroxicam or its saltsPDL I DEC / 13
Pizotyline or its saltsPDL I DEC / 13
Plecanatide PDL I NOV / 19
Plerixafor or its saltsPDL I DEC / 13
Pneumococcal 7-valent conjugate vaccine II JAN / 04
Pneumococcal polysaccharide vaccines II FEB / 02
PodophyllotoxinPDL

When recommended for topical use.

I DEC / 13
PolidocanolPDL

When indicated for administration by injection.

I JAN / 16
Poliomyelitis vaccine II DEC / 98
Polyacrylamide II SEP / 98
Polyethylene glycol topical administration U
Polyethylene glycol 3350 as a single ingredient oral product indicated as a laxative to treat occasional constipation U JUL / 10
Polymyxin B or its salts or derivativesPDL

For human use - except for topical use or for local action in the oral cavity or nasal passages.

I DEC / 13
Polymyxin B or its salts or derivatives.PDL

For veterinary use - when sold in combination with other medicinal ingredients.

I APR / 16
Polymyxin B or its salts or derivatives..

for human, ophthalmic use

III JUN / 06
Polymyxin or its salts or derivatives for human, topical use U
Polysulfated glycosaminoglycanPDL I DEC / 13
Pomalidomide or its saltsPDL I FEB / 14
Ponatinib or its saltsPDL I MAY / 15
Poractant alfaPDL I DEC / 13
Porfimer or its saltsPDL I DEC / 13
PosaconazolePDL I DEC / 13
Potassium bromidePDL I DEC / 13
Potassium citratePDL

When recommended for the treatment of renal tubular acidosis and kidney stones.

I DEC / 13
Potassium gluconatePDL

For veterinary use - when sold or recommended for administration to cats.

I DEC / 13
Potassium para-aminobenzoatePDL

Except in preparations for topical use on the skin.

I DEC / 13
Potassium salts

In preparations for injection.

I DEC / 99
Potassium salts. in oral preparations containing more than 5 mmol per single dose [except potassium bromide, potassium gluconate when sold or recommended for administration to cats, potassium para-aminobenzoate, potassium citrate when recommended for the treatment of renal tubular acidosis and kidney stones] II DEC / 13
Povidone - iodine vaginal preparations, except in concentrations of 5% or less II SEP / 98
Pradofloxacin or their salts or derivativesPDL I MAR / 15
Pralatrexate or its saltsPDL I DEC / 18
Pralidoxime or its saltsPDL I DEC / 13
Pramipexole or its saltsPDL I DEC / 13
Pramoxine and its salts for ophthalmic or parenteral use II SEP / 98
Pramoxine and its salts.

for topical use on mucous membranes, except lozenges

III SEP / 98
Pramoxine and its salts.. for topical application on the skin, and including lozenges U DEC / 05
PrasteroneC3 I JUN / 02
Prasugrel or its saltsPDL I DEC / 13
Pravastatin or its saltsPDL I DEC / 13
Prazepam and its saltsTS I SEP / 98
PraziquantelPDL

For human use.

I DEC / 13
PraziquantelPDL

For veterinary use - except when sold for the treatment of the tapeworm Anoplocephala perfoliata in horses.

I DEC / 13
Prazosin or its saltsPDL I DEC / 13
Pregabalin or its salts or derivativesPDL I DEC / 13
Prenylamine or its saltsPDL I DEC / 13
Prilocaine and its salts

for ophthalmic or parenteral use

II SEP / 98
Prilocaine and its salts.

for topical use on mucous membranes, except lozenges

III SEP / 98
Primaquine or its saltsPDL I DEC / 13
PrimidonePDL

For human use.

I DEC / 13
ProbarbitalC2 I JUN / 02
Probenecid or its saltsPDL I DEC / 13
ProbucolPDL I DEC / 13
Procainamide or its saltsPDL I DEC / 13
Procaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Procaine and its salts for ophthalmic or parenteral use II SEP / 98
Procarbazine or its saltsPDL I DEC / 13
Procaterol or its saltsPDL I DEC / 13
Prochlorperazine or its saltsPDL I DEC / 13
Procyclidine or its saltsPDL I DEC / 13
Prodilidine or its saltsPDL I DEC / 13
Profenamine or its saltsPDL

Including but not limited to ethopropazine.

I DEC / 13
Progesterone or its derivativesPDL

For veterinary use - except when recommended for use in progesterone implants indicated for growth promotion, melengestrol acetate in feed for the suppression of estrus in beef heifers.

I DEC / 13
Proguanil or its saltsPDL I DEC / 13
ProheptazineN I JUN / 02
Promazine or its saltsPDL

For human use.

I DEC / 13
Promethazine and its salts except for topical use II SEP / 98
Promethazine and its salts for topical use III SEP / 98
Propafenone or its saltsPDL I DEC / 13
PropallylonalC2 I JUN / 02
Propantheline and its salts II SEP / 98
Proparacaine and its salts for ophthalmic or parenteral use II SEP / 98
Proparacaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
ProperidineN I JUN / 02
PropiramN I JUN / 02
Propiverine or its saltsPDL I MAR / 17
PropofolPDL I DEC / 13
Propranolol or its saltsPDL I DEC / 13
Propylene glycol topical application U
Propylhexedrine II SEP / 98
Proquamezine [aminopromazine] and its salts

For internal use.

I SEP / 98
Prostaglandins or their salts or derivatives or analoguesPDL

Including but not limited to: Alprostadil, bimatoprost, cloprostenol, dinoprostone, epoprostenol, fluprostenol, latanoprost, latanoprostene bunod, lubiprostone, misoprostol, tafluprost, travoprost, treprostinil, unoprostone.

I AUG / 15
Protamine and its salts II SEP / 98
Prothipendyl hydrochloridePDL I DEC / 13
ProtirelinPDL I DEC / 13
Protriptyline or its saltsPDL I DEC / 13

213 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled